- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
VERLINVEST / CRC / JV
M.8169
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Disclaimer :
The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.
Description of the concentration
On 18 August 2016, the European Commission received notification of a proposed concentration pursuant to Article 4 of the EU Merger Regulation by which Verlinvest SA (“Verlinvest”) and China Resources (Holdings) Co. Limited (“CRC”), through its wholly-owned subsidiary Blossom Key Holdings Limited (“Blossom”), will acquire joint control over Resources Verlinvest Health Investment Ltd. (“JVCo”), within the meaning of Article 3(1)(b) of the EU Merger Regulation.
The primary business activities of the undertakings concerned are as follows:
-Verlinvest, is a Belgian family-owned diversification investment holding company whose principal business is to conduct private and public equity investments in the branded consumer goods industry, including food & beverages, retail and hospitality and digital and media.
-CRC, is a company incorporated in Hong Kong which is primarily involved in various sectors including power generation, gas, real estate, consumer products, construction materials (cement), pharmaceuticals, finance, consumer retail, healthcare, microelectronics, textiles and chemicals.
-JVCo is incorporated in Hong Kong and its business will be to invest in companies which engage in the development and/or sale of food & beverages products that promote a healthy lifestyle and the provision of community healthcare services, primarily in the People’s Republic of China.
The parties entered into a Subscription Agreement on 26 May 2016. The Transaction is subject to obtaining prior clearance from the European Commission.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.